- Report
- January 2025
- 183 Pages
Global
From €4004EUR$4,500USD£3,525GBP
- Report
- October 2025
- 189 Pages
Global
From €3155EUR$3,545USD£2,777GBP
€3505EUR$3,939USD£3,085GBP
- Report
- October 2025
- 285 Pages
Global
From €5206EUR$5,850USD£4,582GBP
- Report
- January 2025
- 200 Pages
Global
From €2216EUR$2,490USD£1,950GBP
- Report
- April 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,517GBP
- Report
- March 2023
- 450 Pages
Global
From €4644EUR$5,402USD£3,950GBP
- Report
- December 2023
- 88 Pages
Global
From €4405EUR$4,950USD£3,877GBP
- Report
- March 2025
- 110 Pages
Brazil
From €3515EUR$3,950USD£3,094GBP
- Report
- July 2024
- 144 Pages
Global
From €5295EUR$5,950USD£4,661GBP
- Report
- July 2024
- 100 Pages
Global
From €2670EUR$3,000USD£2,350GBP
€3337EUR$3,750USD£2,937GBP
- Report
- August 2023
- 145 Pages
Global
From €2803EUR$3,150USD£2,467GBP
- Report
- January 2024
- 150 Pages
Global
From €3426EUR$3,850USD£3,016GBP
€4316EUR$4,850USD£3,799GBP
- Report
- February 2024
- 92 Pages
Global
From €3500EUR$4,213USD£3,189GBP
The Therapeutic Respiratory Devices market is a subset of the larger Respiratory Devices market. It includes devices used to treat respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. These devices are used to deliver medication, humidify air, and provide oxygen therapy. They can also be used to monitor lung function and detect early signs of respiratory distress.
Therapeutic Respiratory Devices are typically used in hospitals, clinics, and home settings. They are designed to improve patient comfort and quality of life, as well as reduce the risk of complications from respiratory diseases.
Some companies in the Therapeutic Respiratory Devices market include Philips Respironics, ResMed, Fisher & Paykel Healthcare, and Vyaire Medical. Show Less Read more
